iMFLUX Revenue and Competitors
Estimated Revenue & Valuation
- iMFLUX's estimated annual revenue is currently $15M per year.
- iMFLUX's estimated revenue per employee is $197,368
Employee Data
- iMFLUX has 76 Employees.
- iMFLUX grew their employee count by -53% last year.
iMFLUX's People
Name | Title | Email/Phone |
---|---|---|
1 | Intellectual Property Manager | Reveal Email/Phone |
2 | Senior Controls Engineer - Team Manager | Reveal Email/Phone |
3 | Manufacturing Engineer | Reveal Email/Phone |
iMFLUX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $200.3M | 798 | 8% | N/A | N/A |
What Is iMFLUX?
With iMFLUX, your sites run more reliably with fewer operator adjustments. You’ll produce higher quality parts, reduce costs, and lower capital—all while advancing your sustainability efforts. \n\niMFLUX is the only molding company that integrates game-changing processing software and machine learning with a mold building and innovation center. We provide the way to autonomous molding with a new capability to design and mold that impossible part. Our revolutionary low-constant-pressure injection molding platform works on virtually any machine, material, and mold.\n\nOur team will help you realize breakthrough results and create a competitive advantage while solving difficult molding problems. We equip your team to simplify and optimize your molding operations—unlocking your ability to deliver more adaptive, reliable, and predictive processes.
keywords:N/AN/A
Total Funding
76
Number of Employees
$15M
Revenue (est)
-53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
iMFLUX News
... N.C.; Imflux, a Hamilton, Ohio, subsidiary of Procter & Gamble with a low-constant-pressure injection molding technology.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.7M | 77 | 7% | N/A |
#2 | $7.5M | 78 | 0% | N/A |
#3 | $25.2M | 78 | -13% | N/A |
#4 | $17.4M | 79 | 7% | N/A |
#5 | N/A | 79 | 13% | N/A |